L Zumstein

Affiliations

Department of Oncology, University Hospital San Luigi Gonzaga, University of Turin, Orbassano, Turin, Italy.

Réseau de co-auteurs

Lucrezia Zumstein 2 collaborations

Maria Giuseppina Annetta 1 collaboration

Davide Celentano 1 collaboration

Giorgio Attinà 1 collaboration

Antonio Ruggiero 1 collaboration

Giorgio Conti 1 collaboration

Mauro Pittiruti 1 collaboration

R M Ruggeri 1 collaboration

B Altieri 1 collaboration

P Razzore 1 collaboration

F Retta 1 collaboration

E Sperti 1 collaboration

G Scotto 1 collaboration

M P Brizzi 1 collaboration

A Pia 1 collaboration

A Lania 1 collaboration

E Lavezzi 1 collaboration

G Nappo 1 collaboration

A Laffi 1 collaboration

M Albertelli 1 collaboration

M Boschetti 1 collaboration

I Hasballa 1 collaboration

A Veresani 1 collaboration

N Prinzi 1 collaboration

S Pusceddu 1 collaboration

S Oldani 1 collaboration

F Nichetti 1 collaboration

R Modica 1 collaboration

R Minotta 1 collaboration

A Liccardi 1 collaboration

G Cannavale 1 collaboration

E M Grossrubatscher 1 collaboration

M G Tarsitano 1 collaboration

V Zamponi 1 collaboration

M C Zatelli 1 collaboration

I Zanata 1 collaboration

R Mazzilli 1 collaboration

M Appetecchia 1 collaboration

M V Davì 1 collaboration

V Guarnotta 1 collaboration

E Giannetta 1 collaboration

A La Salvia 1 collaboration

G Fanciulli 1 collaboration

P Malandrino 1 collaboration

A M Isidori 1 collaboration

A Colao 1 collaboration

A Faggiano 1 collaboration

None None 1 collaboration

Sara Notarnicola 1 collaboration

Jessica Paparo 1 collaboration

Laura Marandino 1 collaboration

Francesco Perrone 1 collaboration

Massimo Di Maio 1 collaboration

L Zumstein

Affiliations

Publications (3)

Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices.

Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.

Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments.

Réseau de co-auteurs